Who Supplies Oseltamivir? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Oseltamivir exports, with 118+ registered manufacturers shipping to buyers across 79+ countries — yet a handful of companies dominate the shipments. NATCO PHARMA LIMITED holds the largest share at 8.4% (export value: $10.3M). Close behind, MSN LABORATORIES PRIVATE LIMITED (4.8%, $5.9M). LUPIN LIMITED (3.3%, $4.0M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Oseltamivir? Top Manufacturers & Their Buyers
Flow of Oseltamivir from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Oseltamivir Supplier Network — Key Market Intelligence
The Oseltamivir export market from India is led by NATCO PHARMA LIMITED, which alone commands a 8.4% share, shipping $10.3M worth of product across 176 shipments. The second-largest exporter, MSN LABORATORIES PRIVATE LIMITED, contributes $5.9M (4.8%) to the overall market. Combined, the top two suppliers alone account for 13.2% of all Oseltamivir exports, indicating a relatively concentrated supply base.
Across all 118 tracked manufacturers, the total Oseltamivir export value stands at $122.6M from 2.1K shipments. The market average shipment value is $57.1K. The single largest buyer relationship in terms of trade value is NATCO PHARMA (CANADA)INC, receiving $5.9M worth of product.
The combined buyer network spans 15 named purchasing companies, including NATCO PHARMA (CANADA)INC, CHONGQING PHARMACEUTICAL(GROUP) CO., NATCOFARMA DO BRASIL, NANJING JULY PHARMACEUTICAL TECHNOL, NOVADOZ PHARMACEUTIC and 10 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1NATCO PHARMA LIMITED
NATCO PHARMA LIMITED is the first-largest Oseltamivir exporter from India, with a market share of 8.4% and a total export value of $10.3M across 176 shipments. Their average shipment value of $58.6K is above the market average of $57.1K, suggesting premium or bulk contract pricing.
NATCO PHARMA LIMITED serves 5 named buyers in our database. NATCO PHARMA (CANADA)INC is the dominant customer, accounting for 57.1% of this supplier's tracked business. Top customers include:
• NATCO PHARMA (CANADA)INC — $5.9M across 101 shipments (57.1% of this supplier's total exports)
• NATCO PHARMA (CANADA)INC — $1.6M across 28 shipments (16.0% of this supplier's total exports)
• CHONGQING PHARMACEUTICAL(GROUP) CO. — $1.3M across 22 shipments (12.5% of this supplier's total exports)
• NATCOFARMA DO BRASIL — $888.8K across 15 shipments (8.6% of this supplier's total exports)
• CHONGQING PHARMACEUTICAL(GROUP) CO. — $601.2K across 10 shipments (5.8% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED's per-shipment value of $58.6K is 3% above the market average of $57.1K, consistent with large-order contracts or value-added formulations.
2MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the second-largest Oseltamivir exporter from India, with a market share of 4.8% and a total export value of $5.9M across 245 shipments. Their average shipment value of $24.0K is below the market average of $57.1K, reflecting a high-volume, competitive pricing strategy.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $2.4M across 100 shipments (40.9% of this supplier's total exports)
• NANJING JULY PHARMACEUTICAL TECHNOL — $2.0M across 83 shipments (33.9% of this supplier's total exports)
• NOVADOZ PHARMACEUTIC — $723.7K across 30 shipments (12.3% of this supplier's total exports)
• NANJING JULY PHARMACEUTICAL TECHNOL — $453.2K across 19 shipments (7.7% of this supplier's total exports)
• NANJING JULY PHARMACEUTICAL TECHNOL — $306.4K across 13 shipments (5.2% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED operates with high shipment frequency (245 shipments) at a per-shipment value of $24.0K, indicating a broad distribution network with many smaller, regular orders.
3LUPIN LIMITED
LUPIN LIMITED is the third-largest Oseltamivir exporter from India, with a market share of 3.3% and a total export value of $4.0M across 184 shipments. Their average shipment value of $21.7K is below the market average of $57.1K, reflecting a high-volume, competitive pricing strategy.
LUPIN LIMITED serves 5 named buyers in our database. UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 89.6% of this supplier's tracked business. Top customers include:
• UPS SUPPLY CHAIN SOL — $3.6M across 165 shipments (89.6% of this supplier's total exports)
• GENERIC HEALTH — $220.4K across 10 shipments (5.5% of this supplier's total exports)
• VIRTROL PHARM CO., L — $161.5K across 7 shipments (4.0% of this supplier's total exports)
• VIRTROL PHARM CO., L — $34.7K across 2 shipments (0.9% of this supplier's total exports)
• YABAO PHARMACEUTICAL — $704 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: LUPIN LIMITED operates with high shipment frequency (184 shipments) at a per-shipment value of $21.7K, indicating a broad distribution network with many smaller, regular orders.
4HETERO LABS LIMITED
HETERO LABS LIMITED is the fourth-largest Oseltamivir exporter from India, with a market share of 3.2% and a total export value of $3.9M across 240 shipments. Their average shipment value of $16.1K is below the market average of $57.1K, reflecting a high-volume, competitive pricing strategy.
HETERO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $1.6M across 97 shipments (40.3% of this supplier's total exports)
• TO THE ORDER OF — $652.6K across 40 shipments (16.8% of this supplier's total exports)
• TO THE ORDER OF — $652.6K across 40 shipments (16.8% of this supplier's total exports)
• GREEPINE PHARMA GROU — $627.3K across 39 shipments (16.2% of this supplier's total exports)
• To The Order — $381.0K across 24 shipments (9.8% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED operates with high shipment frequency (240 shipments) at a per-shipment value of $16.1K, indicating a broad distribution network with many smaller, regular orders.
5ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the fifth-largest Oseltamivir exporter from India, with a market share of 2.8% and a total export value of $3.5M across 75 shipments. Their average shipment value of $46.4K is below the market average of $57.1K, reflecting a high-volume, competitive pricing strategy.
ZYDUS LIFESCIENCES LIMITED serves 1 named buyer in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES — $3.5M across 75 shipments (100.0% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED operates with high shipment frequency (75 shipments) at a per-shipment value of $46.4K, indicating a broad distribution network with many smaller, regular orders.
6STRIDES PHARMA SCIENCE LIMITED
STRIDES PHARMA SCIENCE LIMITED is the fifth-largest Oseltamivir exporter from India, with a market share of 1.8% and a total export value of $2.2M across 66 shipments. Their average shipment value of $33.6K is below the market average of $57.1K, reflecting a high-volume, competitive pricing strategy.
STRIDES PHARMA SCIENCE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• STRIDES PHARMA INC — $650.6K across 19 shipments (29.3% of this supplier's total exports)
• STRIDES SOUTH AFRICA — $547.8K across 16 shipments (24.7% of this supplier's total exports)
• STRIDES PHARMA INC — $447.7K across 13 shipments (20.2% of this supplier's total exports)
• GERMAX SDN BHD — $339.0K across 10 shipments (15.3% of this supplier's total exports)
• SANDOZ CANADA INC., — $234.3K across 7 shipments (10.6% of this supplier's total exports)
Key Insight: STRIDES PHARMA SCIENCE LIMITED operates with high shipment frequency (66 shipments) at a per-shipment value of $33.6K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Oseltamivir Flows
Once Oseltamivir leaves the manufacturing plants of companies like NATCO PHARMA LIMITED and MSN LABORATORIES PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $122.6M. United States absorbs the largest share at 59.0% ($72.4M), followed by China (10.7%) and Canada (10.6%).
In United States — the top destination — named importers include EVERSANA LIFE SCIENCE SERVICES, STRIDES PHARMA INC, AMNEAL PHARMACEUTICALS, LLC (KY). In China, key buyers are NANJING JULY PHARMACEUTICAL TECHNOL, CHONGQING PHARMACEUTICAL (GROUP) CO, CHONGQING PHARMACEUTICAL GROUP.
This geographic spread reflects Oseltamivir's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Oseltamivir Go? Top Importing Countries & Their Buyers
Trade flow of Oseltamivir exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Oseltamivir imports from India, with a total trade value of $72.4M across 220 shipments — representing a 59.0% share of all Oseltamivir exports. The average shipment value of $329.0K is above the global average of $57.1K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.
Named Oseltamivir importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 13.5% ($9.8M) of this market's total imports.
• EVERSANA LIFE SCIENCE SERVICES — $9.8M (13.5% of United States's total)
• STRIDES PHARMA INC — $8.9M (12.3% of United States's total)
• AMNEAL PHARMACEUTICALS, LLC (KY) — $5.3M (7.4% of United States's total)
Key Insight: United States's per-shipment average of $329.0K (477% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Oseltamivir imports from India.
2China
China ranks as the second-largest destination for Oseltamivir imports from India, with a total trade value of $13.1M across 64 shipments — representing a 10.7% share of all Oseltamivir exports. The average shipment value of $205.2K is above the global average of $57.1K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Oseltamivir importers in China: NANJING JULY PHARMACEUTICAL TECHNOL is the largest buyer, accounting for 15.2% ($2.0M) of this market's total imports.
• NANJING JULY PHARMACEUTICAL TECHNOL — $2.0M (15.2% of China's total)
• CHONGQING PHARMACEUTICAL (GROUP) CO — $1.8M (13.5% of China's total)
• CHONGQING PHARMACEUTICAL GROUP — $1.3M (9.8% of China's total)
Key Insight: China's per-shipment average of $205.2K (260% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
China is a key market for Oseltamivir imports from India.
3Canada
Canada ranks as the third-largest destination for Oseltamivir imports from India, with a total trade value of $13.0M across 75 shipments — representing a 10.6% share of all Oseltamivir exports. The average shipment value of $172.8K is above the global average of $57.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Oseltamivir importers in Canada: NATCO PHARMA (CANADA) INC is the largest buyer, accounting for 73.4% ($9.5M) of this market's total imports.
• NATCO PHARMA (CANADA) INC — $9.5M (73.4% of Canada's total)
• NATCO PHARMA CANADA INC — $1.6M (12.7% of Canada's total)
• NATCO PHARMA (CANADA)INC — $1.3M (9.8% of Canada's total)
Key Insight: Canada's per-shipment average of $172.8K (203% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Oseltamivir imports from India.
4Ukraine
Ukraine ranks as the fourth-largest destination for Oseltamivir imports from India, with a total trade value of $5.1M across 6 shipments — representing a 4.1% share of all Oseltamivir exports. The average shipment value of $844.2K is above the global average of $57.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Oseltamivir importers in Ukraine: MACLEODS PHARMACEUTICAL LIMITED LLC is the largest buyer, accounting for 95.9% ($4.9M) of this market's total imports.
• MACLEODS PHARMACEUTICAL LIMITED LLC — $4.9M (95.9% of Ukraine's total)
Key Insight: Ukraine's per-shipment average of $844.2K (1380% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ukraine is a key market for Oseltamivir imports from India.
5Philippines
Philippines ranks as the fifth-largest destination for Oseltamivir imports from India, with a total trade value of $2.2M across 0 shipments — representing a 1.8% share of all Oseltamivir exports. The average shipment value of $2.2M is above the global average of $57.1K, indicating high-value procurement contracts or branded formulations.
Key Insight: Philippines's per-shipment average of $2.2M (3814% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Oseltamivir imports from India.
People Also Ask — Oseltamivir Supplier & Trade Network
Who are the top suppliers of Oseltamivir from India?+
Which companies buy Oseltamivir from Indian manufacturers?+
Where does Oseltamivir exported from India go?+
What is the market share of the top Oseltamivir supplier from India?+
What is the average shipment value for Oseltamivir exports from India?+
Is Oseltamivir manufactured in India and exported globally?+
Which country imports the most Oseltamivir from India?+
Who are the buyers of Oseltamivir in China?+
How concentrated is the Oseltamivir supplier market in India?+
How do I find verified buyers for Oseltamivir in specific countries?+
Oseltamivir Trade Network — Key Takeaways
- 1NATCO PHARMA LIMITED is India's dominant Oseltamivir exporter with a 8.4% market share and $10.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 118 suppliers collectively account for 24.3% of all tracked Oseltamivir exports, with a combined trade value of $122.6M.
- 3United States is the largest destination market, absorbing 59.0% of India's Oseltamivir exports ($72.4M). China (10.7%) and Canada (10.6%) follow.
- 4With 2.1K total shipments averaging $57.1K each, the Oseltamivir export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include NATCO PHARMA (CANADA)INC, NATCO PHARMA (CANADA)INC, NANJING JULY PHARMACEUTICAL TECHNOL, NOVADOZ PHARMACEUTIC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 79 countries
Network value: $122.6M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oseltamivir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Oseltamivir.
- 2.Flow Mapping: 118 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,149 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 79 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,149 Verified Shipments
118 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists